Press release
Rising Breast And Gastric Cancer Prevalence Drives Trastuzumab Biosimilars Market.: A Key Driver Powering Trastuzumab Biosimilars Market Growth In 2025
Trastuzumab Biosimilars
What Is the Trastuzumab Biosimilars Market Size and Projected Growth Rate?
The trastuzumab biosimilars market has seen rapid growth in recent years. It will grow from $4.27 billion in 2024 to $5.43 billion in 2025, at a compound annual growth rate (CAGR) of 27.1%. Growth is attributed to market expansion and increased global reach, patent expirations allowing market entry, rapid biosimilar development, clinical efficacy validation, and competitive pricing.
The trastuzumab biosimilars market is expected to experience significant growth, reaching $14.69 billion in 2029 at a CAGR of 28.3%. Growth is driven by increased market competition, biosimilar development, regulatory approvals, global market penetration, and physician adoption. Major trends include improved access, market segmentation, educational campaigns, patient preference for biosimilars, and physician acceptance.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3400
What Are the Major Segments in the Trastuzumab Biosimilars Market?
The trastuzumab biosimilars market covered in this report is segmented -
1) By Product: Ogivri, Herzuma, Ontruzant, Trazimera, Other Products
2) By Indication: Adjuvant Breast Cancer, Metastatic Breast Cancer, Metastatic Gastric Cancer, Other Indications
3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3400&type=smp
What Are The Driving Trastuzumab Biosimilars Market Evolution?
The growing incidence of breast and gastric cancer is driving the trastuzumab biosimilars market. Trastuzumab biosimilars are used to treat HER2 overexpressing breast cancer and metastatic gastric cancer. According to the American Cancer Society, in 2023, around 297,790 new cases of invasive breast cancer will be diagnosed in women, and approximately 43,700 women will die from the disease. Additionally, in India, breast cancer is the most common cancer among women, accounting for 14% of female cancers. The rising prevalence of these cancers is increasing the demand for trastuzumab biosimilars, which offer a cost-effective alternative to expensive treatments, thus boosting the trastuzumab biosimilars market.
Which Firms Dominate The Trastuzumab Biosimilars Market Segments?
Major companies operating in the trastuzumab biosimilars market include Pfizer Inc., Merck & Co., Amgen Inc., Teva Pharmaceutical Industries Ltd., Mylan NV, Fujifilm Kyowa Kirin Biologics Co. Ltd., Innovent Biologics Inc., STADA Arzneimittel AG, Apotex Inc., Samsung Bioepis Co. Ltd., Celltrion Inc., Zydus Lifesciences Limited, BIOCAD, Shanghai Henlius Biotech Inc., Biocon Limited, Alvotech Holdings S.A., Polpharma Biologics S.A, EirGenix Inc., Hetero Biopharma Limited, Mabion SA, ALTEOGEN Inc., Prestige BioPharma Limited, AryoGen Pharmed Co. Ltd., Intas Pharmaceuticals Limited, Glenmark Pharmaceuticals Ltd., Dr. Reddy's Laboratories Limited, Torrent Pharmaceuticals Limited
What Are the Latest Developing Trends in the Trastuzumab Biosimilars Market?
Companies in the trastuzumab biosimilars market are focusing on new product launches in untapped regions to solidify their market position. These companies are also expanding their product portfolios through strategic initiatives such as new product development and partnerships. For instance, in April 2024, Accord BioPharma Inc., a US-based pharmaceutical company, announced the FDA approval of HERCESSI (trastuzumab-strf), a biosimilar to Herceptin (trastuzumab), used for the treatment of several forms of HER2-overexpressing cancers. HERCESSI works by binding to the HER2 receptor, inhibiting its activity, and slowing cancer cell replication.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/trastuzumab-biosimilar-global-market-report
Which Is The Largest Region In The Trastuzumab Biosimilars Market?
The countries covered in the trastuzumab biosimilars market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Trastuzumab Biosimilars Market?
2. What is the CAGR expected in the Trastuzumab Biosimilars Market?
3. What Are the Key Innovations Transforming the Trastuzumab Biosimilars Industry?
4. Which Region Is Leading the Trastuzumab Biosimilars Market?
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.
Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Breast And Gastric Cancer Prevalence Drives Trastuzumab Biosimilars Market.: A Key Driver Powering Trastuzumab Biosimilars Market Growth In 2025 here
News-ID: 4057637 • Views: …
More Releases from The Business Research Company
Market Structure, Emerging Trends, and Key Player Analysis in Space Elevator Ope …
The concept of space elevators is rapidly moving from science fiction to a tangible future technology, promising revolutionary changes in how we access and utilize space. As interest and investment in this area grow, the market for space elevator operations is set to expand significantly. Below is an overview of the forecasted market size, key players, emerging trends, and the segmentation of this exciting industry.
Projected Market Growth of Space Elevator…
Competitive Analysis: Leading Companies and New Entrants in the Space Currency a …
The emerging space currency and economy sector is poised for remarkable expansion as humanity's ventures beyond Earth gain momentum. With innovations in financial technologies tailored for the unique challenges of space commerce, this market is set to transform how transactions and economic activities unfold across orbital and interplanetary environments. Let's explore the projected growth, key players, market drivers, evolving trends, and the detailed segmentation shaping this futuristic industry.
Projected Market Size…
Multi Object Kill Vehicle Market Overview, Key Trends, and Insights on Major Pla …
The multi object kill vehicle market is poised for significant expansion in the coming years, driven by advancements in missile defense technologies and evolving global security needs. As nations enhance their strategic defense systems, the demand for sophisticated and effective kill vehicle solutions continues to rise, promising substantial growth and innovation in this sector.
Projected Market Size and Growth Trajectory of the Multi Object Kill Vehicle Market
The global multi object…
Competitive Landscape: Leading Companies and New Entrants in the Mission Managem …
The mission management systems market is set to experience significant growth in the coming years, driven by technological advancements and increasing demand across various sectors. This evolving field is rapidly integrating innovative features such as artificial intelligence and cloud-based platforms, which are transforming how missions are planned, executed, and monitored. Let's explore the current market size, leading companies, emerging trends, and the key segments defining this industry.
Projected Growth and Market…
More Releases for Trastuzumab
Leading Growth Driver in the Trastuzumab Biosimilars Market in 2025: Rising Brea …
What Are the Market Size and Growth Forecast for the Trastuzumab Biosimilars Market?
The market for trastuzumab biosimilars has witnessed significant expansion in the past few years. The market is projected to increase from $4.27 billion in 2024 to $5.43 billion in 2025, with a compound annual growth rate (CAGR) of 27.1%. The historical growth patterns can be attributed to the expansion and globalization of the market, expiry of patents and…
Leading Growth Driver in the Trastuzumab Biosimilars Market in 2025: Rising Brea …
What Are the Market Size and Growth Forecast for the Trastuzumab Biosimilars Market?
The market for trastuzumab biosimilars has witnessed significant expansion in the past few years. The market is projected to increase from $4.27 billion in 2024 to $5.43 billion in 2025, with a compound annual growth rate (CAGR) of 27.1%. The historical growth patterns can be attributed to the expansion and globalization of the market, expiry of patents and…
Herceptin (Trastuzumab) Market Overview,Recent Devolopment And Forecast During ( …
This report presents an overview of global market for Herceptin (Trastuzumab), capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Herceptin (Trastuzumab), also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Herceptin (Trastuzumab), and key regions/countries of…
Trastuzumab Biosimilar Market Opportunities and Growth Challenges Report 2022-20 …
Global Trastuzumab Biosimilar Market 2022-2028 - Global Industry Size, Supply Analysis, Price Analysis, Consumption and Production, Supplier and Cost Structure Analysis
Trastuzumab Biosimilar Market Overview
The recent market intelligence study by the research analysts at Market Business Insights (MBI) takes a deep dive into inner operations of the global Trastuzumab Biosimilar Market. It thoroughly examines the market landscape to give the readers an accurate insight into the current, as well as the…
Trastuzumab Biosimilar Market 2022 | Detailed Report
According to Market Study Report, Trastuzumab Biosimilar Market provides a comprehensive analysis of the Trastuzumab Biosimilar Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5511273
The report provides a comprehensive analysis of company profiles listed below:
- Amgen Inc.
- Pfizer Inc
- Samsung Bioepis
-…
Global Trastuzumab Market:Competitive Landscape & Key Player Tactics| Genentech …
LOS ANGELES, United States: QY Research as of late produced a research report titled, “Global Trastuzumab Market Research Report 2020". The research report speak about the potential development openings that exist in the worldwide market. The report is broken down on the basis of research procedures procured from historical and forecast information. The global Trastuzumab market is relied upon to develop generously and flourish as far as volume and incentive…
